IDiyas

For the Inventor, By the Inventor

Yawata, Japan

Tadao Okegawa

USPTO Granted Patents = 15

Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 55(Granted Patents)


Location History:

  • Kyoto, JP (1988)
  • Mishima, JP (1991)
  • Yawata, JP (1987 - 1993)
  • Osaka, JP (1991 - 1995)

Company Filing History:

goldMedal15 out of 574 
 
Ono Pharmaceutical Co., Ltd.
 patents

Years Active: 1987-1995

Loading Chart...
15 patents (USPTO):Explore Patents
1. 5403850 - Derivatives of P-substituted phenyl ester of pivalic acid (1995-04-04),
2. 5336681 - Derivatives of p-substituted phenyl ester of pivalic acid (1994-08-09),
3. 5221689 - Prostaglandin analogues, processes for their preparation and (1993-06-22),
4. 5109021 - Prostaglandin analogues, process for their preparation and (1992-04-28),
5. 5059607 - Imidazolyl benzisoquinolines useful as 5-HT.sub.3 receptor antagonists (1991-10-22),
6. 5023268 - 3-phenoxy (or phenylthio)-cyclopentanecarbonylamino acid analogues (1991-06-11),
7. 5017610 - Derivatives of p-substituted phenyl ester of pivalic acid (1991-05-21),
8. 4935446 - Prostaglandin analogues, process for their preparation and (1990-06-19),
9. 4916147 - 3-[(4-Aroyl) phenoxy (or phenylthio)]-cyclopentanecarboxylic acid (1990-04-10),
10. 4888351 - 3-phenoxy (or phenylthia) cyclopentanecarbonylamino acid analogues (1989-12-19),
11. 4829078 - 3-phenoxy (or phenylthio)--cyclopentanecarbonylamino acid analogues (1989-05-09),
12. 4792550 - 13-aza-14-oxo-TXA.sub.2 analogues (1988-12-20),
13. 4783480 - 6-keto-prostaglandin E.sub.1 derivatives (1988-11-08),
14. 4783476 - 3-Phenoxy (or phenylthio)-cyclopentanecarbonylamino acid analogues (1988-11-08),
15. 4640931 - 3-(indian-5-yloxy (or thio)) cyclopentanecarboxylic acid analogues (1987-02-03),

Title: **Innovative Contributions of Tadao Okegawa**

Introduction

Tadao Okegawa is a notable inventor based in Yawata, Japan, renowned for his significant contributions to the field of pharmaceutical chemistry. With a remarkable portfolio of 15 patents to his name, Okegawa has demonstrated a consistent commitment to innovation and advancements in medicinal applications.

Latest Patents

Among his latest inventions, Okegawa has developed derivatives of P-substituted phenyl ester of pivalic acid. These patents detail derivatives with specific chemical formulas aimed at exhibiting inhibitory activity on elastase. This innovation has potential therapeutic applications, particularly for treating conditions such as pulmonary emphysema, atherosclerosis, and rheumatoid arthritis. The complexity of these chemical compounds highlights his in-depth knowledge and expertise in creating beneficial medical solutions.

Career Highlights

Okegawa is currently associated with Ono Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His work within this organization has allowed him to push the boundaries of research and innovation in drug development. His contributions not only enhance patient care but also exemplify the role of inventors in advancing medical science.

Collaborations

Throughout his career, Tadao Okegawa has collaborated with esteemed colleagues like Katsuhiro Imaki and Yoshinobu Arai. These partnerships signify the importance of teamwork in achieving groundbreaking results in the field of science and technology, further enhancing the impact of their collective innovations.

Conclusion

In conclusion, Tadao Okegawa's impressive portfolio of patents and his collaborative efforts at Ono Pharmaceutical Co., Ltd. underline his critical role in the ongoing evolution of pharmaceutical inventions. His work continues to be instrumental in addressing complex medical challenges, and his dedication to innovation will likely lead to further advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…